Discovery and structural optimization of potent epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M/C797S resistance mutation for lung cancer treatment-Reference-Cited by-同舟云学术

Discovery and structural optimization of potent epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M/C797S resistance mutation for lung cancer treatment

Published:2022-07 Issue: Volume:237 Page:114381
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Cheng,Wang Xin,Huang Zhi,Wang Tianqi,Nie Yongwei,Yang Shengyong,Xiang Rong,Fan Yan

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference48 articles.

1. The ErbB/HER family of protein-tyrosine kinases and cancer;Roskoski;Pharmacol. Res.,2014

2. The role of EGFR in influenza pathogenicity: multiple network-based approaches to identify a key regulator of non-lethal infections;Mitchell;Front. Cell Dev. Biol.,2019

3. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N. Engl. J. Med.,2009

4. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat. Rev. Cancer,2007

5. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer;Baselga;J. Clin. Oncol.,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancer;European Journal of Medicinal Chemistry;2024-11

2. Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential;Archiv der Pharmazie;2024-05-16

3. Structural Insights into the Binding Mode of a BLU-945 Analog with Wild-Type and Mutant EGFRs;Journal of Computational Biophysics and Chemistry;2024-03-16

4. Design, synthesis and biological evaluation of potent epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors against resistance mutation for lung cancer treatment;Bioorganic Chemistry;2024-02

5. Machine Learning-Based Virtual Screening and Identification of the Fourth-Generation EGFR Inhibitors;ACS Omega;2024-01-02